Biagini Lab
Publications

Publications

Biagini Myers, JM; Schauberger, E; He, H; Martin, LJ; Kroner, J; Hill, GM; Ryan, PH; LeMasters, GK; Bernstein, DI; Lockey, JE; et al. A Pediatric Asthma Risk Score to better predict asthma development in young children. Journal of Allergy and Clinical Immunology. 2019; 143:1803-1810.e2.

DeVore, SB; Stevens, ML; He, H; Biagini, JM; Kroner, JW; Martin, LJ; Khurana Hershey, GK. Novel role for caspase recruitment domain family member 14 and its genetic variant rs11652075 in skin filaggrin homeostasis. Journal of Allergy and Clinical Immunology. 2022; 149:708-717.

Murrison, LB; Ren, X; Preusse, K; He, H; Kroner, J; Chen, X; Jenkins, S; Johansson, E; Biagini, JM; Weirauch, MT; et al. TSLP disease-associated genetic variants combined with airway TSLP expression influence asthma risk. Journal of Allergy and Clinical Immunology. 2022; 149:79-88.

Johnson, CC; Havstad, SL; Ownby, DR; Joseph, CL M; Sitarik, AR; Biagini Myers, J; Gebretsadik, T; Hartert, TV; Khurana Hershey, GK; Jackson, DJ; et al. Pediatric asthma incidence rates in the United States from 1980 to 2017. Journal of Allergy and Clinical Immunology. 2021; 148:1270-1280.

Johansson, E; Martin, LJ; He, H; Chen, X; Weirauch, MT; Kroner, JW; Khurana Hershey, GK; Biagini, JM. Second-hand smoke and NFE2L2 genotype interaction increases paediatric asthma risk and severity. Clinical and Experimental Allergy. 2021; 51:801-810.

Zhu, T; Zhang, X; Chen, X; Brown, AP; Weirauch, MT; Guilbert, TW; Khurana Hershey, GK; Biagini, JM; Ji, H. Nasal DNA methylation differentiates severe from non-severe asthma in African-American children. Allergy: European Journal of Allergy and Clinical Immunology. 2021; 76:1836-1845.

Sherenian, MG; Kothari, A; Biagini, JM; Kroner, JW; Baatyrbek kyzy, A; Johannson, E; Atluri, G; He, H; Martin, LJ; Khurana Hershey, GK. Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis. Clinical and Experimental Allergy. 2021; 51:666-673.

Brooks, CC; Martin, LJ; Pilipenko, V; He, H; LeMasters, GK; Lockey, JE; Bernstein, DI; Ryan, PH; Hershey, GK K; Myers, JM B. NAT1 genetic variation increases asthma risk in children with secondhand smoke exposure. Journal of Asthma (Informa). 2021; 58:284-292.

Ryan, PH; Brokamp, C; Blossom, J; Lothrop, N; Miller, RL; Beamer, PI; Visness, CM; Zanobetti, A; Andrews, H; Bacharier, LB; et al. A distributed geospatial approach to describe community characteristics for multisite studies. Journal of Clinical and Translational Science. 2021; 5:e86.

Gonzalez, T; Stevens, ML; Kyzy, AB; Alarcon, R; He, H; Kroner, JW; Spagna, D; Grashel, B; Sidler, E; Martin, LJ; et al. Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort. Allergy: European Journal of Allergy and Clinical Immunology. 2021; 76:302-313.

Stevens, ML; Gonzalez, T; Schauberger, E; Baatyrbek kyzy, A; Andersen, H; Spagna, D; Kalra, MK; Martin, LJ; Haslam, D; Herr, AB; et al. Simultaneous skin biome and keratinocyte genomic capture reveals microbiome differences by depth of sampling. Journal of Allergy and Clinical Immunology. 2020; 146:1442-1445.

Schuler, CL; Myers, JM B; Kercsmar, CM; Pilipenko, VV; Kroner, JW; Simmons, JM; Austin, SR; Gunkelman, SM; Ross, KR; McCoy, KS; et al. Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository. Journal of Asthma (Informa). 2020; 57:1280-1287.

Stevens, ML; Zhang, Z; Johansson, E; Ray, S; Jagpal, A; Ruff, BP; Kothari, A; He, H; Martin, LJ; Ji, H; et al. Disease-associated KIF3A variants alter gene methylation and expression impacting skin barrier and atopic dermatitis risk. Nature Communications. 2020; 11:4092.

Myers, JM B; Sherenian, MG; Kyzy, AB; Alarcon, R; An, A; Flege, Z; Morgan, D; Gonzalez, T; Stevens, ML; He, H; et al. Events in Normal Skin Promote Early-Life Atopic Dermatitis-The MPAACH Cohort. Journal of Allergy and Clinical Immunology: In Practice. 2020; 8:2285-2293.e6.

Schauberger, E; Myers, JM B; He, H; Martin, LJ; Arshad, SH; Kurukulaaratchy, R; Hershey, GK K. Use of the Pediatric Asthma Risk Score to predict allergic and nonallergic asthma. Annals of Allergy, Asthma, and Immunology. 2020; 124:629-631.e2.

Ober, C; McKennan, CG; Magnaye, KM; Altman, MC; Washington, C; Stanhope, C; Naughton, KA; Rosasco, MG; Bacharier, LB; Billheimer, D; et al. Expression quantitative trait locus fine mapping of the 17q12-21 asthma locus in African American children: a genetic association and gene expression study. The Lancet Respiratory Medicine. 2020; 8:482-492.

Kroner, JW; Kyzy, AB; Burkle, JW; Martin, LJ; LeMasters, GK; Bernstein, DI; Lockey, JE; Ryan, P; Hershey, GK K; Myers, JM B. Atopic dermatitis independently increases sensitization above parental atopy: The MPAACH study. Journal of Allergy and Clinical Immunology. 2020; 145:1464-1466.

McAlees, JW; Baker, T; Kaur, D; McKnight, C; Lindsley, A; Strait, RT; Zhang, X; Myers, JM B; Kovacic, MB; Lewkowich, IP. Age and early maternal smoking contribute to epithelial cell IL-13 responsiveness in a pediatric asthma population. Allergy: European Journal of Allergy and Clinical Immunology. 2019; 74:2485-2487.

Sherenian, MG; Myers, JM B; Martin, LJ; Hershey, GK K. The pediatric asthma risk score (PARS): making the move to the most accurate pediatric asthma risk screening tool. Expert Review of Clinical Immunology. 2019; 15:1115-1118.

Johansson, E; Myers, JM B; Martin, LJ; He, H; Ryan, P; LeMasters, GK; Bernstein, DI; Lockey, J; Hershey, GK K. Identification of two early life eczema and non-eczema phenotypes with high risk for asthma development. Clinical and Experimental Allergy. 2019; 49:829-837.

Biagini Myers, JM; Schauberger, E; He, H; Martin, LJ; Kroner, J; Hill, GM; Ryan, PH; LeMasters, GK; Bernstein, DI; Lockey, JE; et al. A Pediatric Asthma Risk Score to better predict asthma development in young children. Journal of Allergy and Clinical Immunology. 2019; 143:1803-1810.e2.

A Pediatric Asthma Risk Score to better predict asthma development in young children

pubs-visual1
Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives. Read the Abstract